Zeki AA - Search Results

1

Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models.

Ma W, Wei S, Li Q, Zeng J, Xiao W, Zhou C, Yoneda KY, Zeki AA, Li T. Ma W, et al. Among authors: zeki aa. Mol Cancer Ther. 2024 May 2;23(5):700-710. doi: 10.1158/1535-7163.MCT-23-0458. Mol Cancer Ther. 2024. PMID: 38237027

2

The adult asthmatic.

Zeki AA, Kenyon NJ, Yoneda K, Louie S. Zeki AA, et al. Clin Rev Allergy Immunol. 2012 Aug;43(1-2):138-55. doi: 10.1007/s12016-011-8260-4. Clin Rev Allergy Immunol. 2012. PMID: 21424682 Review.

3

The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.

Louie S, Zeki AA, Schivo M, Chan AL, Yoneda KY, Avdalovic M, Morrissey BM, Albertson TE. Louie S, et al. Among authors: zeki aa. Expert Rev Clin Pharmacol. 2013 Mar;6(2):197-219. doi: 10.1586/ecp.13.2. Expert Rev Clin Pharmacol. 2013. PMID: 23473596 Free PMC article. Review.

4

Vocal Hoarseness and a Subglottic Mass: An Uncommon Diagnosis for a Common Complaint.

Rafizadeh S, Yoneda K, Zeki AA. Rafizadeh S, et al. Among authors: zeki aa. J Investig Med High Impact Case Rep. 2015 May 19;3(2):2324709615587528. doi: 10.1177/2324709615587528. eCollection 2015 Apr-Jun. J Investig Med High Impact Case Rep. 2015. PMID: 26425643 Free PMC article.

5

Mevalonate Cascade Inhibition by Simvastatin Induces the Intrinsic Apoptosis Pathway via Depletion of Isoprenoids in Tumor Cells.

Alizadeh J, Zeki AA, Mirzaei N, Tewary S, Rezaei Moghadam A, Glogowska A, Nagakannan P, Eftekharpour E, Wiechec E, Gordon JW, Xu FY, Field JT, Yoneda KY, Kenyon NJ, Hashemi M, Hatch GM, Hombach-Klonisch S, Klonisch T, Ghavami S. Alizadeh J, et al. Among authors: zeki aa. Sci Rep. 2017 Mar 27;7:44841. doi: 10.1038/srep44841. Sci Rep. 2017. PMID: 28344327 Free PMC article.

6

Simvastatin inhibits goblet cell hyperplasia and lung arginase in a mouse model of allergic asthma: a novel treatment for airway remodeling?

Zeki AA, Bratt JM, Rabowsky M, Last JA, Kenyon NJ. Zeki AA, et al. Transl Res. 2010 Dec;156(6):335-49. doi: 10.1016/j.trsl.2010.09.003. Transl Res. 2010. PMID: 21078495 Free PMC article.

7

Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.

Yeganeh B, Wiechec E, Ande SR, Sharma P, Moghadam AR, Post M, Freed DH, Hashemi M, Shojaei S, Zeki AA, Ghavami S. Yeganeh B, et al. Among authors: zeki aa. Pharmacol Ther. 2014 Jul;143(1):87-110. doi: 10.1016/j.pharmthera.2014.02.007. Epub 2014 Feb 26. Pharmacol Ther. 2014. PMID: 24582968 Free PMC article. Review.

8

Editorial: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part II).

Zeki AA, Yeganeh B, Kenyon NJ, Ghavami S. Zeki AA, et al. Curr Mol Pharmacol. 2017;10(2):74-76. doi: 10.2174/187446721002170301204357. Curr Mol Pharmacol. 2017. PMID: 28440195 Free PMC article. No abstract available.

9

Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition.

Emami A, Shojaei S, da Silva Rosa SC, Aghaei M, Samiei E, Vosoughi AR, Kalantari F, Kawalec P, Thliveris J, Sharma P, Zeki AA, Akbari M, Gordon JW, Ghavami S. Emami A, et al. Among authors: zeki aa. Eur J Pharmacol. 2019 Nov 5;862:172616. doi: 10.1016/j.ejphar.2019.172616. Epub 2019 Aug 23. Eur J Pharmacol. 2019. PMID: 31449810

10

Editorial (Thematic Issue: New Insights into a Classical Pathway: Key Roles of the Mevalonate Cascade in Different Diseases (Part I)).

Ghavami S, Kenyon NJ, Yeganeh B, Zeki AA. Ghavami S, et al. Among authors: zeki aa. Curr Mol Pharmacol. 2017;10(1):3-5. doi: 10.2174/1874467209999160114145952. Curr Mol Pharmacol. 2017. PMID: 26768962 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page